[go: up one dir, main page]

GT200600174A - Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion - Google Patents

Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion

Info

Publication number
GT200600174A
GT200600174A GT200600174A GT200600174A GT200600174A GT 200600174 A GT200600174 A GT 200600174A GT 200600174 A GT200600174 A GT 200600174A GT 200600174 A GT200600174 A GT 200600174A GT 200600174 A GT200600174 A GT 200600174A
Authority
GT
Guatemala
Prior art keywords
pirrolopiridins
compositions
replaced
contain
manufacturing
Prior art date
Application number
GT200600174A
Other languages
English (en)
Inventor
Michael Tabart
Eric Bacque
Frank Halley
Baptiste Ronan
Pascal Desmazeau
Fabrice Viviani
Catherine Souaille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600174A publication Critical patent/GT200600174A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS DE LA FÓRMULA GENERAL I EN LA QUE A,L,AR,RA,Z,Y,W,R1, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON PIRROLOPIRIDINAS SUSTITUÍDAS QUE PRESENTAN ACTIVIDAD ANTICANCERÍGENA, MEDIANTE LA MODULACIÓN DE LA ACTIVIDAD DE PROTEÍNAS, EN ESPECIAL DE QUINASAS.
GT200600174A 2005-04-26 2006-04-26 Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion GT200600174A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504173A FR2884821B1 (fr) 2005-04-26 2005-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
GT200600174A true GT200600174A (es) 2006-12-26

Family

ID=35517344

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600174A GT200600174A (es) 2005-04-26 2006-04-26 Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion

Country Status (33)

Country Link
US (1) US7947706B2 (es)
EP (1) EP1877409B1 (es)
JP (1) JP2008539211A (es)
KR (1) KR20080007229A (es)
CN (1) CN101166739A (es)
AR (1) AR061386A1 (es)
AT (1) ATE433976T1 (es)
AU (1) AU2006239105A1 (es)
BR (1) BRPI0613161A2 (es)
CA (1) CA2605744A1 (es)
CR (1) CR9463A (es)
CY (1) CY1109369T1 (es)
DE (1) DE602006007337D1 (es)
DK (1) DK1877409T3 (es)
DO (1) DOP2006000096A (es)
EA (1) EA012983B1 (es)
ES (1) ES2328629T3 (es)
FR (1) FR2884821B1 (es)
GT (1) GT200600174A (es)
HR (1) HRP20090494T1 (es)
IL (1) IL186523A0 (es)
MA (1) MA29480B1 (es)
MX (1) MX2007013084A (es)
NO (1) NO20075918L (es)
PA (1) PA8671301A1 (es)
PE (1) PE20071420A1 (es)
PL (1) PL1877409T3 (es)
PT (1) PT1877409E (es)
RS (1) RS51136B (es)
SI (1) SI1877409T1 (es)
TN (1) TNSN07360A1 (es)
TW (1) TW200718701A (es)
WO (1) WO2006114520A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
BRPI0719883A2 (pt) * 2006-10-09 2015-05-05 Takeda Pharmaceutical Inibidores de quinase
EP2223925A1 (en) * 2006-10-09 2010-09-01 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
HRP20150642T1 (hr) * 2006-12-22 2015-08-14 Astex Therapeutics Limited BICIKLIÄŚKE HETEROCIKLIÄŚKE TVARI KAO INHIBITORI FGFR-a
JP5442449B2 (ja) 2006-12-22 2014-03-12 アステックス、セラピューティックス、リミテッド 新規化合物
BRPI0814423B1 (pt) 2007-07-17 2022-04-19 Plexxikon, Inc Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) * 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0810902D0 (en) * 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
DE102008052943A1 (de) 2008-10-23 2010-04-29 Merck Patent Gmbh Azaindolderivate
MY160737A (en) 2009-04-03 2017-03-15 Hoffmann La Roche Propane-i-sulfonic acid {3- [5-(4-chloro-phenyl) -1h -pyrrolo [2, 3-b] pyridine-3-carbonyl] -2,4 difluoro-phenyl} - amide compositions and uses thereof
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US20110030037A1 (en) * 2009-07-07 2011-02-03 Vadim Olshansky Zone migration in network access
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
SG10201407129SA (en) 2009-11-06 2014-12-30 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
CN103517710B (zh) 2011-02-07 2017-05-31 普莱希科公司 用于激酶调节的化合物
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
US20150336948A1 (en) * 2012-05-29 2015-11-26 Merck Sharp & Dohme Corp. Isotopically Labeled Biaryl Urea Compounds
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US20140275082A1 (en) * 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
GB201310460D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds
GB201310464D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3254843B2 (ja) * 1993-08-09 2002-02-12 三菱ウェルファーマ株式会社 新規縮合ヘテロ環誘導体
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
WO2003022852A2 (en) * 2001-09-11 2003-03-20 Smithkline Beecham Corporation Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
US7129225B2 (en) * 2001-10-22 2006-10-31 The Research Foundation Of State University Of New York Protection against and treatment of hearing loss
WO2003082868A1 (en) * 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
FR2878849B1 (fr) 2004-12-06 2008-09-12 Aventis Pharma Sa Indoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
WO2006114520A2 (fr) 2006-11-02
MX2007013084A (es) 2008-01-11
WO2006114520A3 (fr) 2007-03-01
AR061386A1 (es) 2008-08-27
JP2008539211A (ja) 2008-11-13
DK1877409T3 (da) 2009-10-05
PA8671301A1 (es) 2006-12-07
FR2884821B1 (fr) 2007-07-06
EP1877409B1 (fr) 2009-06-17
PT1877409E (pt) 2009-09-16
RS51136B (sr) 2010-10-31
US20080139606A1 (en) 2008-06-12
DOP2006000096A (es) 2007-04-15
TW200718701A (en) 2007-05-16
ATE433976T1 (de) 2009-07-15
EP1877409A2 (fr) 2008-01-16
PL1877409T3 (pl) 2009-12-31
KR20080007229A (ko) 2008-01-17
FR2884821A1 (fr) 2006-10-27
AU2006239105A1 (en) 2006-11-02
BRPI0613161A2 (pt) 2010-12-21
CA2605744A1 (fr) 2006-11-02
PE20071420A1 (es) 2007-01-20
EA200702329A1 (ru) 2008-02-28
EA012983B1 (ru) 2010-02-26
CN101166739A (zh) 2008-04-23
CR9463A (es) 2008-02-21
ES2328629T3 (es) 2009-11-16
SI1877409T1 (sl) 2009-12-31
CY1109369T1 (el) 2014-07-02
US7947706B2 (en) 2011-05-24
IL186523A0 (en) 2008-01-20
NO20075918L (no) 2007-11-19
MA29480B1 (fr) 2008-05-02
HRP20090494T1 (hr) 2009-10-31
TNSN07360A1 (en) 2008-12-31
DE602006007337D1 (de) 2009-07-30

Similar Documents

Publication Publication Date Title
GT200600174A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
GT200800258A (es) Compuestos de pirrolo-pirimidina y sus usos
GT200500226A (es) Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa
GT200600197A (es) Compuestos y composiciones como inhibidores de proteina quinasa
GT200600181A (es) Derivados de amida sustituida y metodos de uso
GT200300031A (es) Indazoles substitutos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
GT200500103A (es) 4-fenilamino-quinazolin-6-il-amidas
GT200500242A (es) Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas
GT200600430A (es) Compuestos de carboxiamina y metodos de uso de los mismos
GT200600356A (es) Mezclas fungicidas que contienen anilidas sustituidas de acido 1-metilpirazol-4-ilcarboxilico.
BRPI0611863A2 (pt) composto, bem como composiÇço e kit compreendendo o mesmo, composto intermediÁrio na preparaÇço do mesmo, mÉtodo para tratamento e uso do mesmo
GT200300087A (es) 2-(2,6-diclorofenil)-diarilimidazoles
GT200400161A (es) Piridinonas sustituidas
GT200600306A (es) Inhibidores de glutamato agrecanasa
GT200700077A (es) Compuestos de 4-metilpiridopirimidinona
GT200600205A (es) Nuevos herbicidas
GT200300292A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal
GT200800103A (es) 5-aril isoxazolinas para controlar plagas de invertebrados
GT200500218A (es) Derivados de triazolopiridinilsulfanilo como inhibidores de quinasa map p38
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
GT200500159A (es) (orto-fenil)-anilidas de àcido 1-metil-3-trifluorometil-pirazol-4-carboxìlico y su uso como fungicida
GT200300257A (es) Fungicidas
GT200600167A (es) Derivados de dihidrobenzofurano y usos de los mismos
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
GT200300033A (es) Derivados de nicotinamida utiles como inhibidores de pde4